Inactive Instrument

Analyst Reco. Sorrento Therapeutics, Inc. Deutsche Boerse AG

Equities

Dawson James Downgrades Sorrento Therapeutics to Neutral Rating From Buy	13/23/13	MT
Cantor Fitzgerald Initiates Sorrento Therapeutics at Overweight With $5 Price Target	02/22/02	MT
HC Wainwright Adjusts Sorrento Therapeutics' Price Target to $20 From $26, Reiterates Buy Rating	25/22/25	MT
SORRENTO THERAPEUTICS : HC Wainwright Adjusts Sorrento Therapeutics' Price Target to $26 From $30, Keeps Buy Rating	09/21/09	MT
SORRENTO THERAPEUTICS : B. Riley Starts Sorrento Therapeutics at Buy With $26 Price Target	29/21/29	MT
SORRENTO THERAPEUTICS : Alliance Global Partners Starts Sorrento Therapeutics at Buy With $35 Price Target	21/21/21	MT

No results for this search